Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/10/1998 | WO1998055508A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS |
12/10/1998 | WO1998055507A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain |
12/10/1998 | WO1998055502A1 METHODS FOR RAPID CLONING OF FULL LENGTH cDNAs |
12/10/1998 | WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
12/10/1998 | WO1998055490A1 Novel class of nucleic acid cationic transfecting agents |
12/10/1998 | WO1998055150A1 Txu-7-pap immunotoxin and use thereof |
12/10/1998 | WO1998055146A1 IDENTIFICATION OF HUMAN HEAVY CHAIN ANTIBODY FRAGMENT DIRECTED AGAINST HUMAN PLATELET ALLOANTIGEN 1a(HPA-1a) |
12/10/1998 | WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use |
12/10/1998 | WO1998055137A1 Bone morphogenetic proteins and their use in bone growth |
12/10/1998 | WO1998055136A1 Fsh-releasing peptides |
12/10/1998 | WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals |
12/10/1998 | WO1998055110A2 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION |
12/10/1998 | WO1998054980A2 Carbohydrate-based enzyme granulates |
12/10/1998 | WO1998054963A2 207 human secreted proteins |
12/10/1998 | WO1998054961A2 Plant transformation methods |
12/10/1998 | WO1998054954A1 Fatty acid elongases |
12/10/1998 | WO1998047343A3 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages |
12/10/1998 | WO1998042831A3 Chimeric genes and methods for increasing the lysine content of the seeds of plants |
12/10/1998 | WO1998041188A3 Stable particle in liquid formulations |
12/10/1998 | WO1998040497A3 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
12/10/1998 | WO1998039472A3 Method for detecting mutated allels |
12/10/1998 | WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
12/10/1998 | WO1998039429A3 Compositions for treatment of disorders involving programmed cell death |
12/10/1998 | WO1998038339A3 Nucleic acid based detection of cytomegalovirus |
12/10/1998 | WO1998038325A3 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells |
12/10/1998 | WO1998036059A3 Prion propagation inhibition by dominant-negative prion protein mutants |
12/10/1998 | WO1998033893A3 Ribozymes cleaving epidermal growth factor receptors |
12/10/1998 | WO1998033478A3 Rna- and dna-based active agents in nanoparticles |
12/10/1998 | WO1998029538A3 Gene for adenylate cyclase and its use |
12/10/1998 | WO1998022575A3 Nucleotide sequence of escherichia coli pathogenicity islands |
12/10/1998 | DE19724039A1 DNS-Sequenzen, Expression dieser DNS-Sequenzen, durch die DNS-Sequenzen kodierte thermophile Laccasen sowie deren Verwendung DNA sequences, expression of these DNA sequences encoded by the DNA sequences and their use thermophilic laccases |
12/10/1998 | CA2293693A1 Anti-gpiib/iiia recombinant antibodies |
12/10/1998 | CA2293664A1 Fsh-releasing peptides |
12/10/1998 | CA2293296A1 Human proteins having transmembrane domains and dnas encoding these proteins |
12/10/1998 | CA2292899A1 Ntn-2 member of tnf ligand family |
12/10/1998 | CA2292896A1 Attachment of unmodified nucleic acids to silanized solid phase surfaces |
12/10/1998 | CA2292892A1 Translational regulator initiation factor 4e-binding protein |
12/10/1998 | CA2292891A1 Zinc ring protein |
12/10/1998 | CA2292842A1 Method for reducing expression variability of transgenes in plants cells |
12/10/1998 | CA2292840A1 Mitofusin genes and their uses |
12/10/1998 | CA2292838A1 Lactoferrin receptor genes of moraxella |
12/10/1998 | CA2292837A1 Novel class of nucleic acid cationic transfecting agents |
12/10/1998 | CA2292835A1 Ntn-2 member of tnf ligand family |
12/10/1998 | CA2292795A1 Indirect genotypic method for diagnosing type 2 familial hemiplegic migraine |
12/10/1998 | CA2292778A1 Plant amino acid biosynthetic enzymes |
12/10/1998 | CA2292770A1 Fatty acid elongases |
12/10/1998 | CA2292766A1 Diacylglycerol acyl transferase proteins |
12/10/1998 | CA2292760A1 Vector |
12/10/1998 | CA2292759A1 Reagents and methods useful for detecting diseases of the urinary tract |
12/10/1998 | CA2292728A1 A method to map and isolate regions of chromosomes that interact or associate functionally within or between chromosomes in vivo |
12/10/1998 | CA2292723A1 Dna sequences, expression of said dna sequences, thermopile laccases coded by said dna sequences and the use thereof |
12/10/1998 | CA2292643A1 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein |
12/10/1998 | CA2292426A1 Txu-7-pap immunotoxin and use thereof |
12/10/1998 | CA2291862A1 New selection marker |
12/10/1998 | CA2291661A1 New human ribonuclease |
12/10/1998 | CA2291485A1 Secreted proteins and polynucleotides encoding them |
12/10/1998 | CA2291452A1 Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity |
12/10/1998 | CA2291260A1 207 human secreted proteins |
12/10/1998 | CA2291116A1 Rapid methods for identifying modifiers of cellular apoptosis activity |
12/10/1998 | CA2291010A1 Herpes simplex virus vp22 vaccines and methods of use |
12/10/1998 | CA2289564A1 Preparation of glycosylated tumor necrosis factor |
12/10/1998 | CA2289491A1 Retroviral vector particles produced in a baculovirus expression system |
12/10/1998 | CA2289479A1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain |
12/10/1998 | CA2288988A1 Methods for rapid cloning of full length cdnas |
12/10/1998 | CA2287848A1 Prion protein modulator factor (ppmf) and prion resistant animals |
12/10/1998 | CA2283422A1 Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants |
12/10/1998 | CA2262463A1 New uses for compounds which reduce c-jun gene expression |
12/10/1998 | CA2262388A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method |
12/10/1998 | CA2234423A1 Processes for preparation of marek's disease virus using continuous mammalian cell lines |
12/10/1998 | CA2234411A1 Novel compounds |
12/10/1998 | CA2206673A1 Use of molecular markers for genotype determination of the ogura rf gene in brassica napus |
12/09/1998 | EP0882979A1 Electrode holder comprising at least one covered electrode and reading-out system |
12/09/1998 | EP0882796A2 Nucleic acid molecules encoding Streptococcus pneumoniae rnc protein, and compositions comprising the same |
12/09/1998 | EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof |
12/09/1998 | EP0882794A2 Human complementarity determining region (CDR)-grafted antibody to ganglioside gm2 |
12/09/1998 | EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene |
12/09/1998 | EP0882792A2 CSB5, a member of the guanine nucleotide exchange factor (GEF) family of polypeptides |
12/09/1998 | EP0882791A2 WNT-11 polypeptides |
12/09/1998 | EP0882790A1 Traf family molecule, polynucleotide coding for the molecule, and antibody against the molecule |
12/09/1998 | EP0882228A1 Methods to identify modulators of cell signaling |
12/09/1998 | EP0882140A2 Process for recognizing the risk of becoming ill after an arthropod bite |
12/09/1998 | EP0882134A1 Methods and compositions for protective and therapeutic genetic immunization |
12/09/1998 | EP0882133A1 Regulation of gene expression in eukaryotes |
12/09/1998 | EP0882132A2 A human cytomegalovirus combined antigen and its use |
12/09/1998 | EP0882131A1 Polypeptides having mutanase activity and nucleic acids encoding same |
12/09/1998 | EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
12/09/1998 | EP0882129A1 Recombinant expression of s-layer proteins |
12/09/1998 | EP0882128A1 Cell-based assay |
12/09/1998 | EP0882127A1 Ungulate embryonic stem-like cells, methods of making and using the cells to produce transgenic ungulates |
12/09/1998 | EP0882065A2 Novel human metabotropic glutamate receptor |
12/09/1998 | EP0882060A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
12/09/1998 | EP0881950A1 Temperature-regulating block with temperature-regulating devices |
12/09/1998 | EP0881914A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
12/09/1998 | EP0881913A1 Liposomal-viral dna complexes for treating disease |
12/09/1998 | EP0881884A1 Bacterial delivery system |
12/09/1998 | EP0776224B1 Needleless syringe for particle delivery |
12/09/1998 | EP0689599B1 Chimeric selectins by exchange of domains - uses thereof |
12/09/1998 | EP0636028A4 Self-assembling polynucleotide delivery system. |
12/09/1998 | EP0566579B1 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions |
12/09/1998 | EP0463073B1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA |